Japan Biotech Ventures Surge as Abenomics Cash Spurs Speculation

Japan Biotech Ventures Surge as Abenomics Cash Spurs Speculation

Tomohiro Ohsumi/Bloomberg

Kengo Suzuki, head of Research and Development at Euglena Co., works in the company's laboratory in Tokyo. Euglena, a venture formed by the University of Tokyo, has soared 10-fold this year for the second-best performance on the Tokyo Stock Exchange Mothers Index.